564 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ovarian Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Mediterranean Diet Versus Hypocaloric Diet in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet, restricted calorie;   Other: hypocaloric diet, restricted calorie
2 Recruiting Mediterranean Diet as Treatment for Normal Weight Women With PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet;   Other: normocaloric diet
3 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
4 Not yet recruiting Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Condition: Ovarian Neoplasms
Intervention: Biological: pembrolizumab
5 Recruiting Circadian Variation in Serum-progesterone Levels Following Controlled Ovarian Hyperstimulation.
Condition: Infertility
Intervention:
6 Recruiting Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: Hyperthermic intraperitoneal chemotherapy (HIPEC);   Drug: Carboplatin
7 Not yet recruiting MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Conditions: Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer;   Breast Cancer;   Cancer of Breast;   Cancer of the Breast;   Gastroesophageal Cancer;   Pancreatic Cancer;   Cancer of the Pancreas;   Colorectal Cancer;   Colorectal Carcinoma;   Renal Cancer;   Kidney Cancer;   Cancer of the Kidney;   Cancer of Kidney;   Ovarian Cancer;   Ovary Cancer;   Cancer of the Ovary;   Cancer of Ovary
Intervention: Drug: MEDI4736
8 Not yet recruiting LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer
Conditions: Epithelial Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer;   Gynaecological Malignancy
Intervention: Other: Diagnostic analysis
9 Not yet recruiting Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin
Condition: Ovarian Cancer
Intervention: Drug: Intraperitoneal cisplatin with nanocis
10 Not yet recruiting Effects of Alpha-acid Lipoic in PCOS Women
Condition: Polycystic Ovary Syndrome
Intervention: Drug: Alpha-lipoic acid
11 Recruiting Effects of Melatonin in PCOS Women
Condition: Polycystic Ovary Syndrome
Intervention: Drug: Melatonin
12 Not yet recruiting Anti-programmed Cell Death-1 Ligand 1 (PDL-1) Antibody Atezolizumab, Bevacizumab and Acetyl Salicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: Bevacizumab;   Drug: atezolizumab;   Drug: acetyl salicylic acid;   Drug: placebo
13 Not yet recruiting A Pilot Study of Induction Wee1 Inhibition in Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneum Cancer
Intervention: Drug: AZD1775
14 Not yet recruiting Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
Conditions: Small Cell Lung Carcinoma;   Carcinoma, Squamous Cell of Head and Neck;   Stomach Neoplasms;   Triple Negative Breast Neoplasms;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms;   Esophagogastric Junction Neoplasms
Interventions: Drug: paclitaxel + carboplatin;   Drug: carboplatin + etoposide;   Drug: gemcitabine + carboplatin;   Drug: nab-paclitaxel (paclitaxel-albumin) + carboplatin;   Drug: oxaliplatin + 5-fluorouracil (5FU) + leucovorin (calcium folinate/folinic acid);   Biological: durvalumab;   Biological: tremelimumab
15 Not yet recruiting Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal or Endometrial Cancer
Conditions: Estrogen Receptor Positive;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Recurrent Uterine Corpus Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Drug: Ribociclib
16 Not yet recruiting Study of Niraparib in Combination With Pembrolizumab (MK-3475) in Patients With Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)
Conditions: Triple Negative Breast Cancer;   Ovarian Cancer;   Breast Cancer;   Metastatic Breast Cancer;   Advanced Breast Cancer;   Stage IV Breast Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Interventions: Drug: niraparib;   Biological: pembrolizumab
17 Not yet recruiting Does Vitamin D Break the Vicious Circle of Polycystic Ovarian Syndrome of Insuline Resistance ?
Condition: PCOS
Interventions: Drug: Vitamin D;   Drug: placebo
18 Not yet recruiting A Study of Niraparib Maintenance Treatment in Patients With HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Condition: Ovarian Cancer
Interventions: Drug: Niraparib;   Drug: Placebo
19 Recruiting Sebum Excretion in Neonates of Women With Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome
Intervention: Other: Sebutape
20 Not yet recruiting Electroacupuncture on Hormonal and Glycometabolic Profiles in Women With Polycystic Ovary Syndrome: Study Protocol
Condition: Polycystic Ovary Syndrome
Interventions: Other: Acupuncture;   Other: Placebo-acupuncture group

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years